UBS raises France's Arkema share price target from €57 to €76

03 April 2012 12:20  [Source: ICIS news]

LONDON (ICIS)--UBS has raised French specialty chemical firm Arkema’s share price target from €57 to €76, because the company is expected to benefit from better business conditions in 2012, the investment bank said on Tuesday.

UBS said Arkema expects around €75m ($100m) of incremental earnings before interest, tax, depreciation and amortisation (EBITDA) from acquisitions and capacity expansion.

“We think that after the vinyls divestment [announced in November 2011], perceived earnings volatility has significantly reduced, which should trigger multiple re-rating in the medium term,” the bank added.

UBS said Arkema had recently increased its long-term targets and now expects to achieve €8bn of sales and €1.25bn of EBITDA in 2016.

The bank added that it sees Arkema’s long-term targets as realistic, particularly because the company is already showing signs of resilience in its earnings in 2012.

UBS has maintained its “neutral” rating for Arkema.

($1 = €0.75)

By: Leigh Stringer
+44 208 652 3214

AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly